{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:02:54Z","timestamp":1762542174522},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T00:00:00Z","timestamp":1365033600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s00404-013-2825-9","type":"journal-article","created":{"date-parts":[[2013,4,3]],"date-time":"2013-04-03T05:24:06Z","timestamp":1364966646000},"page":"839-844","source":"Crossref","is-referenced-by-count":5,"title":["The expression of BRCA1, P53, KAI1, and Nm23 in ovaries of BRCA1 mutation carriers after prophylactic adnexectomy"],"prefix":"10.1007","volume":"288","author":[{"given":"J.","family":"Markowska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"M\u0105dry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"S\u0142omska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mardas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P.","family":"Grabowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,4]]},"reference":[{"key":"2825_CR1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.currproblcancer.2006.06.001","volume":"30","author":"EA Reynolds","year":"2006","unstructured":"Reynolds EA, Moller KA (2006) A review and an update on the screening of epithelial ovarian cancer. Curr Probl Cancer 30:203\u2013232","journal-title":"Curr Probl Cancer"},{"key":"2825_CR2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ygyno.2004.02.013","volume":"93","author":"B Rosen","year":"2004","unstructured":"Rosen B, Kwon J, Fung Kee Fung M, Gagliardi A, Chambers A (2004) Systematic review of management options for women with a hereditary predisposition to ovarian cancer. Gynecol Oncol 93:280\u2013286","journal-title":"Gynecol Oncol"},{"key":"2825_CR3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jpag.2004.03.042","volume":"17","author":"B Seeber","year":"2004","unstructured":"Seeber B, Driscoll DA (2004) Hereditary breast and ovarian cancer syndrome: should we test adolescents? J Pediatr Adolesc Gynecol 17:161\u2013167","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"2825_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2005.05.003","volume":"57","author":"M Palma","year":"2006","unstructured":"Palma M, Ristori E, Ricevuto E, Giannini G, Gulino A (2006) BRCA1 and BRCA2: the genetic testing and the current management options for mutation carriers. Criti Rev Oncol Hemat 57:1\u201323","journal-title":"Criti Rev Oncol Hemat"},{"key":"2825_CR5","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.cdip.2004.03.005","volume":"10","author":"I Weinreb","year":"2004","unstructured":"Weinreb I, Colgan TJ (2004) BRCA mutations and pathology in the female genital tract. Curr Diagn Pathol 10:326\u2013335","journal-title":"Curr Diagn Pathol"},{"key":"2825_CR6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1053\/ctrv.2001.0233","volume":"27","author":"MO Nicoletto","year":"2001","unstructured":"Nicoletto MO, Donach M, De Nicolo A, Artioli G, Banna G, Monfardini S (2001) BRCA-1 and BRCA-2 mutations as prognostic factors in clinical practice and genetic counselling. Cancer Treat Rev 27:295\u2013304","journal-title":"Cancer Treat Rev"},{"key":"2825_CR7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.critrevonc.2006.03.003","volume":"60","author":"S Canevari","year":"2006","unstructured":"Canevari S, Gariboldi M, Reid JF, Bongarzone I, Pierotti MA (2006) Molecular predictors of response and outcome in ovarian cancer. Criti Rev Oncol Hemat 60:19\u201337","journal-title":"Criti Rev Oncol Hemat"},{"key":"2825_CR8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1006\/gyno.2001.6366","volume":"83","author":"M Schindl","year":"2001","unstructured":"Schindl M, Birner P, Breitenecker G, Oberhuber G (2001) Downregulation of KAI1 metastasis suppressor protein is associated with a dismal prognosis in epithelial ovarian cancer. Gynecol Oncol 83:244\u2013248","journal-title":"Gynecol Oncol"},{"key":"2825_CR9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1006\/gyno.2002.6729","volume":"86","author":"CD Houle","year":"2002","unstructured":"Houle CD, Ding XY, Foley JF, Afshari CA, Barrett JC, Davis BJ (2002) Loss of expression and altered localization of KAI1 and CD9 protein are associated with epithelial ovarian cancer progression. Gynecol Oncol 86:69\u201378","journal-title":"Gynecol Oncol"},{"key":"2825_CR10","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1038\/sj.onc.1201852","volume":"16","author":"A White","year":"1998","unstructured":"White A, Lamb PW, Barret JC (1998) Frequent downregulation of the KAI1(CD82) metastasis suppressor protein in human cancer cell lines. Oncogene 16:3143\u20133149","journal-title":"Oncogene"},{"key":"2825_CR11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0165-4608(00)00250-8","volume":"121","author":"G Cipollini","year":"2000","unstructured":"Cipollini G, Moretti A, Ghimenti C, Viacava P, Bevilacqua G, Caligo MA (2000) Mutational analysis of the NM23.H1 gene in human breast cancer. Cancer Genet Cytogenet 121:181\u2013185","journal-title":"Cancer Genet Cytogenet"},{"key":"2825_CR12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/gyno.1996.0056","volume":"60","author":"PJ Srivatsa","year":"1996","unstructured":"Srivatsa PJ, Cliby WA, Keeney GL, Dodson MK, Suman VJ, Roche PC, Podratz KC (1996) Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma. Gynecol Oncol 60:363\u2013372","journal-title":"Gynecol Oncol"},{"issue":"2","key":"2825_CR13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1028-4559(09)60206-0","volume":"45","author":"YT Tee","year":"2006","unstructured":"Tee YT, Chen GD, Lin LY, Ko JL, Wang PH (2006) Nm23-h1: a metastasis-associated gene. Taiwanese J Obstet Gynecol 45(2):107\u2013113","journal-title":"Taiwanese J Obstet Gynecol"},{"key":"2825_CR14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/path.1507","volume":"202","author":"C Wang","year":"2004","unstructured":"Wang C, Horiuchi A, Imai T, Ohira S, Itoh K, Nikaido T et al (2004) Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene. J Pathol 202:215\u2013223","journal-title":"J Pathol"},{"key":"2825_CR15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0303-7207(99)00117-3","volume":"155","author":"M Schuyer","year":"1999","unstructured":"Schuyer M, Berns EMJJ (1999) Is TP53 dysfunction required for BRCA1\u2014associated carcinogenesis? Mol Cel Endocrinol 155:143\u2013152","journal-title":"Mol Cel Endocrinol"},{"key":"2825_CR16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-4608(98)00011-9","volume":"105","author":"RA DiCioccio","year":"1998","unstructured":"DiCioccio RA, Werness BA, Peng R, Allen HJ, Piver MS (1998) Correlation of TP53 mutations and p53 overexpression in ovarian tumors. Cancer Genet Cytogenet 105:93\u2013102","journal-title":"Cancer Genet Cytogenet"},{"key":"2825_CR17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1006\/gyno.2000.5801","volume":"78","author":"FS Liu","year":"2000","unstructured":"Liu FS, Dong JT, Chen JT, Hsieh YT, Ho ES, Hung MJ (2000) Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor in epithelial ovarian carcinoma. Gynecol Oncol 78:10\u201315","journal-title":"Gynecol Oncol"},{"key":"2825_CR18","doi-asserted-by":"crossref","first-page":"11307","DOI":"10.1073\/pnas.95.19.11307","volume":"95","author":"T Mashimo","year":"1998","unstructured":"Mashimo T, Watabe M, Hirota S, Hosobe S, Miura K, Tegtmeyer PJ, Rinker-Shaeffer CW, Watabe K (1998) The expression of the KAI1 gene, a tumor metastasis suppressor, is directly acivated by p53. Proc Natl Acad Sci USA 95:11307\u201311311","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2825_CR19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1023\/A:1005597231776","volume":"32","author":"MT Hartsough","year":"2000","unstructured":"Hartsough MT, Steeg PS (2000) Nm23\/Nucleoside diphosphate kinase in human cancers. J Bioenerg Biomemb 32(3):301\u2013308","journal-title":"J Bioenerg Biomemb"},{"issue":"2","key":"2825_CR20","first-page":"97","volume":"3","author":"Q Gao","year":"2004","unstructured":"Gao Q, Ma D, Meng L, Wang S, Wang C, Lu Y et al (2004) Related Study on the Nm23-H1 Gene Expression in the Model of Ovarian Carcinoma Cell Lines with High Frequent Metastasis. Chin-Ger J Clinic Oncol 3(2):97\u2013100","journal-title":"Chin-Ger J Clinic Oncol"},{"key":"2825_CR21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijgo.2006.03.028","volume":"95","author":"U Yalcinkaya","year":"2006","unstructured":"Yalcinkaya U, \u00d6zuysal S, Bilgin T, Ercan I, Saraydaroglu \u00d6, Demir D (2006) Nm23 expression in node-positive and node-negative endometrial cancer. Int J Gyn Obstet 95:35\u201339","journal-title":"Int J Gyn Obstet"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-013-2825-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-013-2825-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-013-2825-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T19:14:35Z","timestamp":1551208475000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-013-2825-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["2825"],"URL":"https:\/\/doi.org\/10.1007\/s00404-013-2825-9","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,4]]}}}